Business Wire

Macrobond Launches AI Data Feed with MCP and Skill, Bringing Governed Macroeconomic Intelligence to Enterprise AI Workflows

10.6.2026 14:00:00 CEST | Business Wire | Press Release

Share

Macrobond today announced the general availability of the Macrobond AI Data Feed Service, a purpose-built product, enabling financial institutions to integrate governed macroeconomic intelligence directly into AI-powered research, investment, and strategy workflows. Available now with MCP, Skill and API delivery components, the AI Data Feed helps organizations accelerate macroeconomic research and insight generation and reduce reliance on fragmented or ungoverned data sources. By delivering reliable, licensed, economic data integrated directly within AI chat interfaces and coding environments, the AI Data Feed Service provides a trusted foundation for enterprise AI initiatives.

As generative AI becomes embedded in research, investment, and strategy workflows, face a foundational challenge: most AI systems operate on ungoverned data producing outputs that are difficult to trust, reproduce, or audit. The Macrobond AI Data Feed Service directly addresses this gap by connecting customer’s AI environment to a structured layer of governed macroeconomic intelligence, backed by AI-specific licensing designed for enterprise use.

"AI adoption is accelerating across research and investment, but the data foundations have not kept up. Institutions are building on fragmented, ungoverned sources that introduce real risk. Our AI Data Feed Service gives analysts and developers a direct connection to Macrobond's licensed macroeconomic intelligence, so our customers can operationalize AI with confidence."

— Stephanie Covert, CEO, Macrobond

Three Delivery Components: MCP, Skill and API

The AI Data Feed Service launches with three complementary interfaces, serving distinct user environments while sharing the same governed data infrastructure.

Macrobond MCP - The conversational interface layer.

MCP connects AI chat interfaces, such as Claude and ChatGPT, to Macrobond Data. Users ask natural language questions and receive economically coherent, sourced data in response. Typical use cases include data exploration, comparative analysis, and AI-assisted research reporting. Macrobond’s MCP server translates each request into specific data queries, Macrobond never receives or stores the original user prompt.

Macrobond Skill - The programmatic interface layer.

Skill enables developers, quants, and AI engineers to access Macrobond intelligence from within coding environments such as Claude Code and GitHub Copilot. Distributed as a lightweight instruction layer, Skill supports the construction of research pipelines, analytical applications, back testing models, and internal AI systems, all with governed, authenticated access to Macrobond data.

Macrobond API - The direct data access layer.

Macrobond API connects data engineers, quants, and developers to the full depth of the Macrobond data via authenticated endpoints. Users query licensed macroeconomic data, metadata, and revision-aware series directly, integrating Macrobond intelligence into proprietary systems, data platforms, and automated pipelines. Typical use cases include: bulk data extraction, scheduled data feeds, model inputs, and platform integrations. Requests are structured and deterministic, access is governed and authenticated throughout.

Key Capabilities

Semantic Macroeconomic Retrieval: Retrieve economically comparable indicators across countries and time periods, with structured hierarchies, metadata-aware search, and consistent cross-country classification.

AI-Native Workflow Integration: Works directly within the tools analysts and developers already use, supporting both conversational interfaces and programmatic pipelines without requiring a new application.

Governed AI Access: AI-specific licensing provides clear rights for generative AI usage, with transparent sourcing, entitlement-aware access, and revision-aware, point-in-time data for reproducible analysis.

Privacy by Design: Customer’s LLM runs in their own environment. Macrobond only processes search and retrieval operations, never the original user prompt or conversation context.

Availability

Macrobond AI Data Feed Service with MCP and Skill is now available. The product is designed for institutions that want to integrate Macrobond’s macroeconomic intelligence into AI workflows, whether through conversational chat interfaces or programmatic coding environments. Access requires an AI Data Feed Service license entitlement, available through the Macrobond sales team.

For more information, visit macrobond.com or contact your Macrobond representative.

About Macrobond

Macrobond is the world’s leading provider of macroeconomic and financial data intelligence. Trusted by central banks, asset managers, investment banks, and research institutions globally, Macrobond delivers structured, governed economic data and analytics through its platform, and data feed. The Macrobond Platform is used by thousands of analysts, economists, and developers to power research, analysis, and investment decisions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260610862002/en/

Contacts

Macrobond Communications
marketing@macrobond.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 16:50:00 CEST | Press Release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive

emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 17:12:00 CEST | Press Release

emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 15:00:00 CEST | Press Release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 15:00:00 CEST | Press Release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press Release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye